Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin

NCT03649113 is registered in ClinicalTrials.gov with Tehran University of Medical Sciences as lead sponsor.

NCT NCT03649113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03649113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Sclerotherapy of Symptomatic Liver Hemangioma With Bleomycin
Lead sponsor
Tehran University of Medical Sciences
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2018
Completion date
July 1, 2020
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemangioma liver